Synlait Milk Share Price: Live NZX Quote, Forecast & Analysis

Synlait Milk has had a rough ride on the NZX. The dairy processor published results in March 2026 that showed a NZD 80.6 million net loss and a recovery roadmap that left investors unconvinced — the stock ended the day up just 2.5% despite what the CEO called “frustratingly disappointing” numbers. A year before, you’d have paid more than twice as much for the same shares. Now that analysts have updated their price targets, it’s worth asking whether the current price reflects a bargain or a value trap.

30 Day High: 0.455 · 30 Day Low: 0.415 · 52 Week High: 0.835 · 52 Week Low: 0.000 · Quick Ratio: 0.25 · Price/Earnings (Normalized): 31.90

Key Synlait Milk (SML.NZ) figures

Six verified financial snapshots from official and broker sources, showing how the first half of 2026 compares against prior periods and where analysts see the stock heading.

Will Synlait recover?

HY26 results overview

Synlait published its HY26 results for the six months ended 31 January 2026 on 23 March 2026, and the numbers drew a blunt assessment from CEO Richard Wyeth: “The numbers we are presenting today are frustratingly disappointing.” Revenue came in at NZD 949 million, up NZD 32.3 million or 3.5% year-over-year — a gain that looks positive until you see what happened to profitability. Gross profit collapsed to just NZD 3.1 million, down NZD 83.9 million from the prior half. The company reported a net loss of NZD 80.6 million and an EBITDA loss of NZD 34.7 million (Investing.com).

Net debt surged 88% to NZD 472.1 million, while the quick ratio sat at a thin 0.25 — a sign the company has limited liquid assets relative to short-term obligations. The North Island operations alone reported a NZD 16.2 million loss on NZD 171.4 million revenue, unchanged from HY25, suggesting regional pressures aren’t easing (Investing.com).

Recovery roadmap details

Three interconnected issues drove the poor results. Manufacturing disruptions at the Dunsandel facility, first reported in July 2025, cascaded into inventory shortfalls that persisted into HY26. Simultaneously, weak whole milk powder pricing hammered returns from Synlait’s ingredients business. The third issue was a deferred tax asset decision that added further financial complexity (Investing.com).

The forward milk price forecast for the 2025/26 season offers some relief: a base price of NZD 9.50 per kg MS, rising to NZD 9.90 per kg MS when premiums are included (Synlait Official). But Synlait’s historical revenue growth — a 13% compound annual rate over the past 13 years — masks a sharp reversal in recent periods. Alpha Spread now projects a -6% revenue CAGR for the next two years, implying the turnaround won’t be quick.

What are analysts’ predictions for Synlait?

Price targets and estimates

Analyst sentiment has turned cautious. Fintel records an average 12-month price target of NZD 0.45, with a low of NZD 0.40 and a high of NZD 0.52 (Fintel). Simply Wall St trimmed its fair value estimate from NZD 0.57 to NZD 0.50 after revising downward revenue growth assumptions and increasing the discount rate (Simply Wall St). Alpha Spread sits at a similar 0.455 NZD average target, with a range of 0.404 to 0.525 (Alpha Spread), while TradingView analysts target 0.46 NZD with a max of 0.50 and min of 0.40 (TradingView).

Forecast consensus

The consensus view points to modest upside from the post-announcement price of NZD 0.41 — roughly 10% above current levels. However, forward P/E sits at an elevated 9.27x relative to the company’s loss-making position, making traditional valuation metrics harder to apply. Simply Wall St forecasts earnings growth of 94.4% per year and EPS growth of 85% annually, with return on equity expected to reach 2.2% in three years — aggressive assumptions given the near-term challenges (Simply Wall St ASX).

Is Synlait a buy?

Pros and cons analysis

Buy recommendations

The investment case hinges on timing. Synlait bulls point to the milk price tailwind, a recovery roadmap, and analyst price targets clustering around NZD 0.45–0.46 — above the post-HY26 trading price. Bears highlight the collapsing gross margins, surging debt, and a quick ratio that offers little buffer if operations worsen. The share price of NZD 0.41 represents a significant discount to where the stock traded a year ago, but value investors should ask whether the current price already bakes in the worst-case scenario.

What is Synlait’s dividend yield currently?

Current yield calculation

Synlait has suspended dividends amid its losses, which means the current yield is effectively 0%. The company has not declared any dividend payments since the financial stress became apparent, and with net debt at NZD 472.1 million and EBITDA deeply negative, a resumption appears unlikely in the near term.

Historical dividends

Prior to the financial deterioration, Synlait was a dividend-paying stock. The suspension reflects the broader pressure on cash generation — a quick ratio of 0.25 leaves little room for shareholder returns while the company funds its recovery. Investors seeking income should look elsewhere.

Will Synlait shares go up?

Short-term drivers

The near-term catalyst is execution of the recovery roadmap. If Synlait resolves the Dunsandel manufacturing issues and benefits from the stronger 2025/26 milk price forecast, the stock could re-rate toward analyst targets of NZD 0.45–0.52. Conversely, another profit warning or executive departure — the Chief Quality Officer resigned on 29 April 2026 — could push prices lower. The market appears to be pricing in substantial risk, with the stock down 37% over the past year.

Long-term outlook to 2030

The longer-term view is murky. Historically, Synlait achieved 13% revenue CAGR over 13 years, but that trend has broken down. The forward projections from Alpha Spread (-6% revenue CAGR) and Simply Wall St (EPS growth of 85% per annum, contingent on margin recovery) suggest a potential rebound — but only if the core manufacturing and margin issues resolve. By 2030, Synlait’s fate will likely depend on whether it restores profitability in its ingredients business and whether milk prices remain supportive.

For New Zealand investors evaluating SML.NZ, the decision breaks down clearly: buy into recovery speculation if you believe the 2025/26 milk price tailwind and manufacturing fix drive a margin rebound, or steer clear until Synlait posts consecutive quarters of improving gross profit and declining net debt. The current price may look cheap, but cheapness without turnaround evidence is a trap. Monitor the next earnings release closely — if gross profit doesn’t improve, the analyst targets of NZD 0.45 may prove optimistic.